Navigation Links
Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips

r longer times in the Saccharopolyspora erythraea mutant strain," Kao said.

Searching for mutations

When researchers reveal how mutants overproduce antibiotics, the real work has only just begun--successful reverse engineering hinges on the ability to reproduce the mechanism of overproduction in new strains. Ideally, the exact sequence of base pairs causing the mutation could be found and then directly introduced into a new strain.

Drug companies use chemicals and radiation to damage DNA and induce mutations. But it's not easy to detect these single base-pair mutations in the so-called industrial mutant strains. Kao's group, for example, detected the presence of an unidentified regulator gene altering the timing of erythromycin production, but could not pinpoint the specific mutation.

A similar study by Kao's group identified two genes responsible for overproduction of the antibiotic tylosin. Instead of increasing the length of time that a bacterium produces the antibiotic--the case with erythromycin--these two genes allow the bacterium to produce it faster. Again, the specific mutations eluded Kao's group.

Currently, the researchers are trying to identify the mutations by chopping overproducer DNA into small pieces, several genes in length, and inserting them into normal bacteria to look for changes in either expression of antibiotic gene clusters or final antibiotic yields.

DNA shuffling

Studying mutant strains that already exist only represents half of Kao's work; she also creates her own mutants. Creating the mutants on her own offers two advantages. First, instead of making mutants with chemicals and radiation, her group uses transposons--small DNA segments that can replicate on their own and insert their copies into new positions anywhere in the genome. Mutations induced by transposons are significantly easier to identify.

A technique called DNA shuffling, recently developed by the Redwood City-ba
'"/>

Source:Stanford University


Page: 1 2 3 4

Related biology news :

1. Chemicals in tattoo inks need closer scrutiny
2. Roots Engage in Underground Chemical Warfare
3. Chemical band-aid prevents heart failure in mice with muscular dystrophy
4. Chemical compound inhibits tumor growth, size in new mouse study
5. T-rays: New imaging technology spotlighted by American Chemical Society
6. Chemical warfare agent detection technology used to treat lung disease
7. Chemical guidance of T cells leads to immunologic memory and long-term immunity
8. Chemical signaling helps regulate sensory map formation in the brain
9. Chemical in many air fresheners may reduce lung function
10. Chemical tests of cell growth enter third dimension
11. Chemicals in brown algae may protect against skin cancer

Post Your Comments:
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In a...he bugs, they have natural enemies called bacterio...th every two days. , Still, bacteria and anothe...scovered in extreme environments such as deep-sea ...rt because they have a built-in defense system tha...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 1BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 3BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 4BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 1King Announces Commercial Availability of EMBEDA 28TM 29 57735 2King Announces Commercial Availability of EMBEDA 28TM 29 57735 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 4King Announces Commercial Availability of EMBEDA 28TM 29 57735 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 6King Announces Commercial Availability of EMBEDA 28TM 29 57735 7King Announces Commercial Availability of EMBEDA 28TM 29 57735 8King Announces Commercial Availability of EMBEDA 28TM 29 57735 9King Announces Commercial Availability of EMBEDA 28TM 29 57735 10King Announces Commercial Availability of EMBEDA 28TM 29 57735 11Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 1Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 2
...chool biologists have figured out the fate of heal...ctious prion form in yeast: The protein converts t...nstant, good protein goes bad. , This quick-change...sterious molecular machinery behind prions, infect... as mad cow disease and scrapie in animals and, in...
...tion about the many things that could go wrong, re... Southeast Asian outbreak of avian influenza in hu... vaccine. , Using a computer model to simulate an ...e scientists have shown how a combination of strat...rals, quarantine and prevaccination -- even with a...
...e hunters and not the last ice age are the likely ...and other North American great mammals such as mam...University of Florida researcher. , Determining wh...f the American continent at the end of the last Ic...c sloths has puzzled scientists because both event...
Other Biology News:Prions rapidly 'remodel' good protein into bad, Brown study shows 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 3Study shows big game hunters, not climate change, killed off sloths 2Study shows big game hunters, not climate change, killed off sloths 3
(Date:11/24/2009)...lue Marble Energy Corp. announced today that the c... (OPDA) were recently awarded $2 million by Washin...rd (CERB) in a private/public partnership to const...finery in Lincoln County, WA. ,, "This invest...ur biorefinery and bring over 70 green jobs to Lin...
(Date:11/24/2009)...s been met for patients with advanced-stage, or... Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...ve efficacy data from a Phase 2 study with its tar...rly AN-152), in patients with advanced or recurren...
(Date:11/24/2009)...re-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHP...ny, today,announced that it has submitted a MAA to...lfa, the company,s enzyme replacement therapy in d...ease. This is the third marketing,application for ...revious,submissions in the United States and Canad...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...mic Health,s Executive Chairman, will present at t...e in New York City on Tuesday, December 1, 2009 at...equently archived webcast of the presentation, vis...h,s website at http://investor.genomichealth.com ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...Inc. (Nasdaq: NVAX ) today announced that it wil... in a press release to be issued after 8:00 a.m. E...ld an investor conference call to discuss its fina...30, 2009. The call will be hosted by Novavax Presi... and other members of senior management. A questi...
... , EDMONTON, March 17 /PRNewswire-FirstCall/ - Bi...n the treatment of multiple sclerosis (MS), today ...e year ended December 31, 2008. , "Dirucotide has ...ession in previous studies and we look forward to ...O-01) in the second half of this year," said Kevin...
...an Biosciences, an emerging leader in systems for ... Sullivan 2009 North American Product Innovation A...that enables children and adults to be screened fo...ntly. Magellan,s President of Clinical Diagnostics...ht at the 2009 Excellence in Medical Technologies ...
Other Biology Technology:Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 2Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 3BioMS Medical Announces 2008 Year End Results 2BioMS Medical Announces 2008 Year End Results 3BioMS Medical Announces 2008 Year End Results 4BioMS Medical Announces 2008 Year End Results 5BioMS Medical Announces 2008 Year End Results 6BioMS Medical Announces 2008 Year End Results 7BioMS Medical Announces 2008 Year End Results 8BioMS Medical Announces 2008 Year End Results 9BioMS Medical Announces 2008 Year End Results 10BioMS Medical Announces 2008 Year End Results 11Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 2Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 3Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 4
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: